<div style="margin: 12px 0px; font-family: arial; color: #333333; background: #ffffff; border: solid 4px #e5e5e5; width: 100%; clear: left;"><div class="CM_CTB_Content_Wrap" style="margin: 0px; padding: 0px;background-color: #ffffff;"><div style="border-bottom: solid 1px #dcdcdc; white-space: nowrap; margin-bottom: 8px; background-color: #eeeeee ;background-image: url(http://clipmarks.com/images/source-bg.gif); background-repeat: repeat-x; height: 24px; line-height: 24px; vertical-align: middle; padding-bottom: 4px; color: #666666; font-size: 10px;" ><a href="http://clipmarks.com/clip-to-blog/" title="see clips that are hot right now"><img src="http://content.clipmarks.com/blog_embed/decd3a17-7ff8-4e56-b71f-ec6da93937cf/67F5A656-90CC-429F-9D41-63D57B774B66/" alt="" width="19" height="19" border="0" style="vertical-align: middle; margin: 0px 4px; display: inline; border: none; float:none;" /></a>clipped from <a title="http://www.guardian.co.uk/science/2008/jul/30/medicalresearch.health?gusrc=rss&feed=science" href="http://www.guardian.co.uk/science/2008/jul/30/medicalresearch.health?gusrc=rss&feed=science" style="font-size: 11px;">www.guardian.co.uk</a></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.guardian.co.uk/science/2008/jul/30/medicalresearch.health?gusrc=rss&feed=science"><P>The Alzheimer's Society last night hailed an apparent breakthrough in the treatment of dementia by scientists at Aberdeen University. A team led by Professor Claude Wischik published results of early trials of a new drug, suggesting it could be at least twice as effective as current medicines in slowing progression of the disease.</P></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.guardian.co.uk/science/2008/jul/30/medicalresearch.health?gusrc=rss&feed=science"><P>The drug, called rember, slowed cognitive decline by 81%, Wischik said in a paper presented to the international conference on Alzheimer's disease in Chicago.</P></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.guardian.co.uk/science/2008/jul/30/medicalresearch.health?gusrc=rss&feed=science"><P>Rember is the first drug to act on a protein called tau that helps brain cells keep their structure and communicate with each other. In people with dementia this protein becomes tangled and causes brain cell death. Wischik's research suggested rember could reduce the tau tangles and slow the deterioration of the brain.</P></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.guardian.co.uk/science/2008/jul/30/medicalresearch.health?gusrc=rss&feed=science"><P>People taking it for 50 weeks had a slower decline in blood flow to the parts of the brain that are important for memory than those taking a dummy pill.</P></blockquote></div><div style="margin: 0px 6px 6px 4px;"><table style="font-size: 11px;border-spacing: 0px;padding: 0px;" cellpadding="0" cellspacing="0" width="100%"><tr><td style="background:transparent;border-width:0px;padding:0px;">&nbsp;</td><td align="right" style="background:transparent;border-width:0px;padding:0px;width:107px" width="107"><a href="http://clipmarks.com/share/67F5A656-90CC-429F-9D41-63D57B774B66/blog/" title="blog or email this clip"><img src="http://content8.clipmarks.com/images/c2b-foot.png" border="0" alt="blog it" width="107" height="17" style="border-width:0px;padding:0px;margin:0px;" /></a></td></tr></table></div></div>

New from the makers of Clipmarks:  Amplify.com - Don't just share the news...Amplify it!